Cargando…

Multidrug Resistance-Associated Protein 2 (MRP2) Mediated Transport of Oxaliplatin-Derived Platinum in Membrane Vesicles

The platinum-based anticancer drug oxaliplatin is important clinically in cancer treatment. However, the role of multidrug resistance-associated protein 2 (MRP2) in controlling oxaliplatin membrane transport, in vivo handling, toxicity and therapeutic responses is unclear. In the current study, prep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Myint, Khine, Li, Yan, Paxton, James, McKeage, Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4488857/ https://www.ncbi.nlm.nih.gov/pubmed/26131551 http://dx.doi.org/10.1371/journal.pone.0130727

Ejemplares similares

Transport-Mediated Oxaliplatin Resistance Associated with Endogenous Overexpression of MRP2 in Caco-2 and PANC-1 Cells
por: Biswas, Riya, et al.
Publicado: (2019)

Identification of MRP2 as a targetable factor limiting oxaliplatin accumulation and response in gastrointestinal cancer
por: Myint, Khine, et al.
Publicado: (2019)

Stereoselective peripheral sensory neurotoxicity of diaminocyclohexane platinum enantiomers related to ormaplatin and oxaliplatin.
por: Screnci, D., et al.
Publicado: (1997)

Predicting effects on oxaliplatin clearance: in vitro, kinetic and clinical studies of calcium- and magnesium-mediated oxaliplatin degradation
por: Han, Catherine H., et al.
Publicado: (2017)

Nucleolar damage correlates with neurotoxicity induced by different platinum drugs
por: McKeage, M J, et al.
Publicado: (2001)

Paclitaxel induces nucleolar enlargement in dorsal root ganglion neurons in vivo reducing oxaliplatin toxicity
por: Jamieson, S M F, et al.
Publicado: (2003)

Structural basis for substrate and inhibitor recognition of human multidrug transporter MRP4
por: Huang, Ying, et al.
Publicado: (2023)

Phase I drug-interaction study of effects of calcium and magnesium infusions on oxaliplatin pharmacokinetics and acute neurotoxicity in colorectal cancer patients
por: Han, Catherine H, et al.
Publicado: (2013)

Platinum and other metal coordination compounds in cancer chemotherapy. A commentary on the sixth international symposium: San Diego, California, 23-26th January 1991.
por: McKeage, M. J., et al.
Publicado: (1991)

Reversal of MRP7 (ABCC10)-Mediated Multidrug Resistance by Tariquidar
por: Sun, Yue-Li, et al.
Publicado: (2013)

Oxaliplatin-induced loss of phosphorylated heavy neurofilament subunit neuronal immunoreactivity in rat DRG tissue
por: Jamieson, Stephen MF, et al.
Publicado: (2009)

Detecting acute neurotoxicity during platinum chemotherapy by neurophysiological assessment of motor nerve hyperexcitability
por: Hill, Andrew, et al.
Publicado: (2010)

Relationships between hydrophobicity, reactivity, accumulation and peripheral nerve toxicity of a series of platinum drugs
por: Screnci, D, et al.
Publicado: (2000)

Involvement of human and canine MRP1 and MRP4 in benzylpenicillin transport
por: Zhao, Xiaofen, et al.
Publicado: (2019)

Lack of nephrotoxicity of oral ammine/amine platinum (IV) dicarboxylate complexes in rodents.
por: McKeage, M. J., et al.
Publicado: (1993)

Mechanism of action of an orally administered platinum complex [ammine bis butyrato cyclohexylamine dichloroplatinum (IV) (JM221)] in intrinsically cisplatin-resistant human ovarian carcinoma in vitro.
por: McKeage, M. J., et al.
Publicado: (1994)

Multidrug transporter MRP4/ABCC4 as a key determinant of pancreatic cancer aggressiveness
por: Sahores, A., et al.
Publicado: (2020)

Localization of the ATP-binding cassette (ABC) transport proteins PfMRP1, PfMRP2, and PfMDR5 at the Plasmodium falciparum plasma membrane
por: Kavishe, Reginald A, et al.
Publicado: (2009)

Reversing Multidrug Resistance in Caco-2 by Silencing MDR1, MRP1, MRP2, and BCL-2/BCL-xL Using Liposomal Antisense Oligonucleotides
por: Lo, Yu-Li, et al.
Publicado: (2014)

The Effect of Albumin on MRP2 and BCRP in the Vesicular Transport Assay
por: Deng, Feng, et al.
Publicado: (2016)

Expression and role of PGP, BCRP, MRP1 and MRP3 in multidrug resistance of canine mammary cancer cells
por: Pawłowski, Karol M, et al.
Publicado: (2013)

Amplification and expression of the ABC transporters ARA and MRP in a series of multidrug-resistant leukaemia cell sublines.
por: O'Neill, G. M., et al.
Publicado: (1998)

Vinblastine and sulfinpyrazone export by the multidrug resistance protein MRP2 is associated with glutathione export
por: Evers, R, et al.
Publicado: (2000)

Correction: Reversing Multidrug Resistance in Caco-2 by Silencing MDR1, MRP1, MRP2, and BCL-2/BCL-xL Using Liposomal Antisense Oligonucleotides
Publicado: (2014)

Inhibitory effect of the reversal agents V-104, GF120918 and Pluronic L61 on MDR1 Pgp-, MRP1- and MRP2-mediated transport
por: Evers, R, et al.
Publicado: (2000)

The Amelioration of N-Acetyl-p-Benzoquinone Imine Toxicity by Ginsenoside Rg3: The Role of Nrf2-Mediated Detoxification and Mrp1/Mrp3 Transports
por: Gum, Sang Il, et al.
Publicado: (2013)

Multidrug resistance-associated protein-1 (MRP1) genetic variants, MRP1 protein levels and severity of COPD
por: Budulac, Simona E, et al.
Publicado: (2010)

Platinum accumulation in oxaliplatin‐induced peripheral neuropathy
por: Wei, Guoli, et al.
Publicado: (2021)

Characterization of SN38-resistant T47D breast cancer cell sublines overexpressing BCRP, MRP1, MRP2, MRP3, and MRP4
por: Lee, Hee-Jeong, et al.
Publicado: (2022)

Expression of the multidrug resistance-associated protein (MRP) gene in colorectal carcinomas.
por: Fillpits, M., et al.
Publicado: (1997)

Role of multidrug resistance protein 2 (MRP2) in chemoresistance and clinical outcome in oesophageal squamous cell carcinoma
por: Yamasaki, M, et al.
Publicado: (2011)

Synthesis and biological evaluation of novel quinoline analogs of ketoprofen as multidrug resistance protein 2 (MRP2) inhibitors
por: Mosaffa, Fatemeh, et al.
Publicado: (2021)

Effect of COPD treatments on MRP1-mediated transport in bronchial epithelial cells
por: van der Deen, Margaretha, et al.
Publicado: (2008)

Genetic variation of the ABC transporter gene ABCC1 (Multidrug resistance protein 1 – MRP1) in the Polish population
por: Słomka, Marcin, et al.
Publicado: (2015)

Human multidrug resistance protein 4 (MRP4) is a cellular efflux transporter for paracetamol glutathione and cysteine conjugates
por: Koenderink, Jan B., et al.
Publicado: (2020)

Transporters MRP1 and MRP2 Regulate Opposing Inflammatory Signals To Control Transepithelial Neutrophil Migration during Streptococcus pneumoniae Lung Infection
por: Zukauskas, Andrew, et al.
Publicado: (2018)

Perturbation of the lipid phase of a membrane is not involved in the modulation of MRP1 transport activity by flavonoids
por: Wesołowska, Olga, et al.
Publicado: (2008)

Membrane expression of MRP-1, but not MRP-1 splicing or Pgp expression, predicts survival in patients with ESFT
por: Roundhill, E, et al.
Publicado: (2013)

Crocin suppresses multidrug resistance in MRP overexpressing ovarian cancer cell line
por: Mahdizadeh, Shadi, et al.
Publicado: (2016)

Functional Expression of Multidrug Resistance Protein 4 MRP4/ABCC4
por: Hardy, David, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bjkvo2t5935bhlgmttob9qsrpo